The Zimmer Biomet Biologics product portfolio represents the
passionate pursuit of the most innovative and clinically relevant
solutions addressing the needs of surgeons and their patients. As a
leader in autologous therapies, Zimmer Biomet Biologics offers a
myriad of solutions for hard tissue applications, including bone
grafting products, platelet and plasma concentration systems, a BBMA
(blood and bone marrow aspirate) concentration system, an autologous
activation system and bone marrow aspiration needles (ancillary
products). Also offered are soft tissue management products.
The philosophy defining our hard tissue products is based on the complex process involved in tissue repair, wherein the matrix/scaffold (osteoconductive), signalling proteins (osteopromotive and osteoinductive), and tissue forming cells (osteogenic) work in concert to form new tissue (bone). This “Bone Remodelling Triad” is the cornerstone of the Zimmer Biomet Biologics product portfolio, which is one of the broadest portfolios in the market today.